Our study showed that TET2 mutation is an independent risk factor for thrombosis in ET patients, and to understand their clinical characteristics and coagulation status, we compared the clinical characteristics and coagulation functions of TET2-mutated and -unmutated patients. This evidence concerns the gene TET2 and essential thrombocythemia.